Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs

The study results suggest that select factors have sufficient evidence to inform care in GEP-NENs, but the evidence for most biomarkers is weak. This article may help guide management and identify gaps for future research to advance personalized medicine and improve outcomes for patients with GEP-NENs.

Authors

Institutions

Publication Details

Journal
JAMA Oncology
Published
2024-10-03
DOI
https://doi.org/10.1001/jamaoncol.2024.4330
Citations
7
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
2.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs

Jennifer Lim, Rachel Goodwin, Jonathan Koea, David Laidley et al.
7 citations
JAMA Oncology
Neuroendocrine Tumor Research Advances
2.71
article

Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs

Jennifer Lim, Rachel Goodwin, Jonathan Koea, David Laidley, Boris G. Naraev, Andrew M. Bellizzi, Sten Myrehaug, Veronica Boyle, David Chan, Jonathan M. Loree, Meredith Cummins, Dale L. Bailey, Janice L. Pasieka, Michael Michael, Simron Singh, Jason Posavad, Sarah Doucette, Heather Stuart, Nicolas Fidelman, J. Del Rivero
article en
7 citations

Abstract

The study results suggest that select factors have sufficient evidence to inform care in GEP-NENs, but the evidence for most biomarkers is weak. This article may help guide management and identify gaps for future research to advance personalized medicine and improve outcomes for patients with GEP-NENs.

JAMA OncologyVol. 10(12)
Western University (CA), BC Cancer Agency (CA), The University of Sydney (AU), National Institutes of Health (US), Lawson Health Research Institute (CA), Sunnybrook Health Science Centre (CA), Garvan Institute of Medical Research (AU), University of British Columbia (CA), University of Ottawa (CA), University of Auckland (NZ), The University of Melbourne (AU), University of Calgary (CA), University of California, San Francisco (US), University of Toronto (CA), Royal North Shore Hospital (AU), Peter MacCallum Cancer Centre (AU), Ottawa Hospital (CA), Auckland City Hospital (NZ), Tampa General Hospital (US), University of Iowa Hospitals and Clinics (US), Princess Margaret Cancer Centre (CA), UNSW Sydney (AU), Cancer Australia (AU), Fluidigm (Canada) (CA), Northern Sydney Local Health District (AU), St George Hospital (AU), National Cancer Institute (US), Impact (CA)
Openalex Percentile: Top 9%
Neuroendocrine Tumor Research Advances
2.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.